Table 2 Cox proportional hazard models by study prior to AIC evaluation
Study | Variable | Hazard ratio | CI 95% | P value |
|---|---|---|---|---|
PLCO | Age | 1.01 | (1, 1.02) | 0.08 |
Age and PSA interaction | 0.89 | (0.85, 0.94) | < 0.001* | |
BMI | 1.01 | (1, 1.02) | 0.07 | |
BPH | 0.88 | (0.81, 0.97) | 0.01* | |
DRE | 1.64 | (1.46, 1.85) | < 0.001* | |
Family history of cancer | 1.43 | (1.27, 1.61) | < 0.001* | |
Finasteride use | 0.69 | (0.6, 0.79) | < 0.001* | |
Log (PSA) | 5.52 | (5.15, 5.93) | < 0.001* | |
African American | 1.37 | (1.15, 1.63) | < 0.001* | |
African American and BMI interaction | 1.05 | (0.89, 1.23) | 0.58 | |
SELECT | Age | 1.01 | (1, 1.02) | 0.03* |
Age and PSA interaction | 0.83 | (0.79, 0.88) | < 0.001* | |
BMI | 1 | (0.99, 1.01) | 1 | |
BPH | 0.84 | (0.75, 0.93) | 0.001* | |
Family history of cancer | 1.72 | (1.58, 1.88) | < 0.001* | |
Finasteride use | 0.98 | (0.77, 1.25) | 0.88 | |
Log (PSA) | 5.3 | (4.92, 5.71) | < 0.001* | |
African American | 1.29 | (1.15, 1.44) | < 0.001* | |
African American and BMI interaction | 1.15 | (1.04, 1.27) | 0.01* |